YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly ...

It makes sense to include routine adult vaccinations to our list of preventative measures, not only for prevention of common ...

In the context of intensified competition in the domestic vaccine industry, AIM Vaccine's Hansen yeast recombinant hepatitis B vaccine saw an increase in sales revenue, standing firm against market ...

titers are significantly higher than those of currently marketed recombinant subunit control vaccines. Compared to similar products using the mRNA technology route, AIM's mRNA shingles vaccine also ...

Desentum Oy, a clinical-stage biopharmaceutical company developing novel immunotherapies for treating allergies, announces positive clinical data with birch pollen allergy vaccine DM-101PX. The ...

Cas9, scientists reconstitute live African swine fever virus from synthetic genomes, accelerating vaccine development for ...

NEET UG 2025: Syllabus, answers to FAQs for Biology(Getty Images ... (Recombinant DNA technology). • Application of Biotechnology in health and agriculture: Human insulin and vaccine production ...

This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.

Credit: Alican Lazutti via Getty Images. GSK is collaborating with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to investigate whether GSK’s shingles vaccine, ...

A new study out of Stanford has presented the strongest evidence to date that a common vaccine could significantly reduce the ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...